Prior Authorization Reform for Autoimmune and Blood Disorders Act | Community Exchange
PolicyNationalOur Government
Prior Authorization Reform for Autoimmune and Blood Disorders Act
A House bill that would require health insurers to cover drugs for autoimmune diseases and certain blood disorders, with limits on prior authorization.
H.R. 9192 is a bill introduced in the U.S. House of Representatives on June 8, 2026, by Ms. Johnson of Texas and Mr. Lawler. It would require health insurance plans to cover drugs used to treat autoimmune diseases, hemophilia, and Von Willebrand disease. It would also limit how often insurers can require prior authorization for these drugs — no more than once every 12 months.
If you or a family member has an autoimmune disease, hemophilia, or Von Willebrand disease, this bill could change how often your insurance asks for special approval before covering your medicine.
